HIV and TB Overview: Mozambique

At a glance

CDC works with partners in Mozambique to strengthen the country's public health and clinical systems, deliver quality HIV testing and treatment services, and respond to emerging public health threats.

Three equal horizontal bands of green (top), black, and yellow with a red isosceles triangle based on the hoist side; the black band is edged in white; centered in the triangle is a yellow five-pointed star bearing a crossed rifle and hoe in black superimposed on an open white book.

Background

CDC has been working with the Government of Mozambique since 2000 and continues to support the country’s response to HIV. CDC works closely with Mozambique’s Ministry of Health to:

  • Deliver HIV prevention and treatment services.
  • Strengthen laboratory HIV surveillance, infrastructure, and workforce capacity.
  • Enhance the country’s response to tuberculosis (TB).

Download CDC Mozambique's Fact Sheet
‎

Learn more about CDC's global HIV and TB work in Mozambique.

HIV and TB data

HIV/AIDS

Estimated HIV Prevalence (Ages 15-49)

Estimated AIDS Deaths (Age≥15)

Estimated Orphans Due to AIDS

Reported Number Receiving Antiretroviral Therapy (Age≥15)

Tuberculosis (TB)

Estimated TB Incidence

TB Patients with Known HIV-Status who are HIV-Positive

TB Treatment Success Rate

Key activities and accomplishments

HIV testing and counseling

CDC leads the implementing agency of U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). During fiscal year (FY) 2022, CDC supported more than 6.1 million HIV tests. These efforts led to the diagnosis and linkage to care of 201,436 people living with HIV (PLHIV) (PEPFAR data 2022).

Supporting universal access to antiretroviral treatment (ART)

From development to implementation of national policies, CDC's efforts have contributed to dramatically increased ART access in Mozambique. As of September 2022, 1,195,428 PLHIV received ART at a CDC-supported health facility.

HIV and TB

TB preventive treatment (TPT) is critical to reducing morbidity and mortality among PLHIV. Addressing TB also entails routine TB and HIV screening, follow-up evaluation, and treatment initiation. In fiscal year 2022, 325,642 PLHIV on ART initiated and completed a form of TPT at a CDC-supported health facility.

Prevention of mother-to-child transmission of HIV

Diagnosing and treating pregnant and lactating women with HIV infection is the most effective approach to eliminating new infections among infants. Throughout FY 2022, 68,625 women, representing 100 percent of pregnant women with HIV infection, were on ART at CDC-supported facilities. These efforts help to prevent mother-to-child transmission of HIV (PEPFAR data 2022).

Voluntary medical male circumcision (VMMC)

With lifelong benefits, VMMC reduces the risk of female-to-male HIV acquisition by approximately 60 percent. The program began in Mozambique in 2010. Since then, CDC and its partners have safely supported the provision of more than 2.1 million male circumcisions.

Resources

Voluntary Circumcision Reduces HIV Infections in Mozambique
Read a story about the remarkable impact VMMC has had on preventing HIV transmission in Mozambique.
Tracking PEPFAR Impact Toward Global Targets
CDC's leadership role in PHIA surveys including where these surveys have been conducted.
Mozambique | Institute for Health Metrics and Evaluation
CDC in Mozambique
Learn about CDC's work in Mozambique.
Print
Content Source:
Global Health Center